Literature DB >> 12102469

Clinical presentations and vascular histopathology in autopsied patients with systemic lupus erythematosus and anticardiolipin antibodies.

A Sipek-Dolnicar1, M Hojnik, B Bozic, A Vizjak, B Rozman, D Ferluga.   

Abstract

OBJECTIVE: To examine histomorphological and immunohistological changes in an autopsy series of systemic lupus erythematosus (SLE) patients with or without anticardiolipin antibodies (aCL).
METHODS: Fourteen SLE patients who died at our department from 1988 to 1996 were included. The patients' medical files were reviewed for the clinical history and the presence of IgG and IgM aCL. Autopsy samples of various organs, including regularly the kidneys, heart, brain and skin, were studied by standard histological methods and the direct immunofluorescence technique.
RESULTS: Thirteen of 14 (93%) autopsied SLE patients were persistently positive for IgG aCL and had common overt thrombotic complications and/or other clinical features related to the antiphospholipid syndrome. Their autopsy tissue samples showed frequent occlusive vascular changes such as bland thromboses, thrombotic microangiopathy (TMA) related changes and arterial intimalfibrous hyperplasia. The immune complex related vascular changes were mostly unremarkable and present mainly in low aCL positive patients, who also had more aggressive types of lupus glomerulonephritis (GN).
CONCLUSION: Increased IgG aCL were found in 13 out of 14 autopsied SLE patients who had predominant occlusive vascular histopathologic changes. The coincidence of bland thromboses with a characteristic TMA histopathology suggested two pathogenetic mechanisms associated with the presence of aCL, one related to abnormal coagulation and the other to endothelial cell injury. The extent of granular vascular immune deposits, typical of SLE, and the severity of lupus GN were inversely related to the aCL level.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12102469

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN: 0392-856X            Impact factor:   4.473


  4 in total

1.  Improvement of irregularity of brain vessel walls in systemic lupus erythematosus by tacrolimus.

Authors:  Hiromi Kizu; Hiroaki Dobashi; Tomohiro Kameda; Kentaro Susaki; Masahiko Kawanishi; Toshihiko Ishida
Journal:  Clin Rheumatol       Date:  2010-11-04       Impact factor: 2.980

Review 2.  Renal manifestations of the antiphospholipid syndrome.

Authors:  David D'Cruz
Journal:  Curr Rheumatol Rep       Date:  2009-02       Impact factor: 4.592

Review 3.  Microthrombotic/microangiopathic manifestations of the antiphospholipid syndrome.

Authors:  Sonja Praprotnik; Dusan Ferluga; Alenka Vizjak; Anastazija Hvala; Tadej Avcin; Blaz Rozman
Journal:  Clin Rev Allergy Immunol       Date:  2009-06       Impact factor: 8.667

4.  Antiphospholipid (Hughes) syndrome: beyond pregnancy morbidity and thrombosis.

Authors:  Maria Mialdea; Shirish R Sangle; David P D'Cruz
Journal:  J Autoimmune Dis       Date:  2009-05-19
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.